126
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Cream of the Crop: Clinical Representativeness of Eligible and Ineligible Cannabis Users in Research

ORCID Icon, , ORCID Icon, &

References

  • Agrawal, A., Lynskey, M. T., Pergadia, M. L., Bucholz, K. K., Heath, A. C., Martin, N. G., & Madden, P. F. (2008). Early cannabis use and DSM-IV nicotine dependence: A twin study. Addiction, 103(11), 1896–1904. doi:10.1111/j.1360-0443.2008.02354.x
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th. ed., text rev.). Washington, DC: Author.
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th . ed.). Washington, DC: Author.
  • Baggio, S., Deline, S., Studer, J., Mohler-Kuo, M., Daeppen, J. B., & Gmel, G. (2014). Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. Journal of Adolescent Health, 54(2), 235–240. doi:10.1016/j.jadohealth.2013.08.013
  • Bates, M. E., Bowden, S. C., & Barry, D. (2002). Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Experimental and Clinical Psychopharmacology, 10(3), 193–212. doi:10.1037/1064-1297.10.3.193
  • Battisti, R. A., Roodenrys, S., Johnstone, S. J., Respondek, C., Hermens, D. F., & Solowij, N. (2010). Chronic use of cannabis and poor neural efficiency in verbal memory ability. Psychopharmacology, 209(4), 319–330. doi:10.1007/s00213-010-1800-4
  • Bland, J. M., & Altman, D. G. (1995). Multiple significance tests: The Bonferroni method. The BMJ, 310(6973), 170–170. doi:10.1136/bmj.310.6973.170
  • Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013). The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 33(2), 195–209. doi:10.1002/phar.1187
  • Bosker, W. M., Karschner, E. L., Lee, D., Goodwin, R. S., Hirvonen, J., Innis, R. B., … Ramaekers, J. G. (2013). Psychomotor function in chronic daily cannabis smokers during sustained abstinence. PLoS ONE, 8(1), e53127. doi:10.1371/journal.pone.0053127
  • Brière, F. N., Fallu, J.-S., Descheneaux, A., & Janosz, M. (2011). Predictors and consequences of simultaneous alcohol and cannabis use in adolescents. Addictive Behaviors, 36(7), 785–788. doi:10.1016/j.addbeh.2011.02.012
  • Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016). Acute and chronic effects of cannabinoids on human cognition – A systematic review. Biological Psychiatry, 79(7), 557–567. doi:10.1016/j.biopsych.2015.12.002
  • Burdzovic Andreas, J., Lauritzen, G., & Nordfjærn, T. (2015). Co-occurrence between mental distress and poly-drug use: A ten-year prospective study of patients from substance abuse treatment. Addictive Behaviors, 48, 71–78. doi:10.1016/j.addbeh.2015.05.001
  • Center for Behavioral Health Statistics and Quality (CBHSQ). (2016a). 2015 National Survey on Drug Use and Health: Detailed tables. Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf
  • Center for Behavioral Health Statistics and Quality. (2016b). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health, ( HHS Publication No. SMA 16–4984, NSDUH Series H-51). Retrieved from http://www.samhsa.gov/data/
  • Compton, W. M., & Baler, R. (2016). The epidemiology of DSM-5 cannabis use disorders among U.S. adults: Science to inform clinicians working in a shifting social landscape. American Journal of Psychiatry, 173(6), 551–553. doi:10.1176/appi.ajp.2016.16030314
  • Conway, K. P., Vullo, G. C., Nichter, B., Wang, J., Compton, W. M., Iannotti, R. J., & Simons-Morton, B. (2013). Prevalence and patterns of polysubstance use in a nationally representative sample of 10th graders in the United States. Journal of Adolescent Health, 52(6), 716–723. doi:10.1016/j.jadohealth.2012.12.006
  • Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., … & Martinez‐Orgado, J. (2014). Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791–802. doi:10.1111/epi.12631
  • Ehrenreich, H., Rinn, T., Kunert, H. J., Moeller, M. R., Poser, W., Schilling, L., … Hoehe, M. R. (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology, 142(3), 295–301. doi:10.1007/s002130050892
  • Ernst, M., Heishman, S. J., Spurgeon, L., & London, E. D. (2001). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology, 25(3), 313–319. doi:10.1016/S0893-133X(01)00257-3
  • Englund, A., Freeman, T. P., Murray, R. M., & McGuire, P. (2017). Can we make cannabis safer? The Lancet Psychiatry, 4(8), 643–648. doi:10.1016/S2215-0366(17)30075-5
  • Farmer, R. F., Kosty, D. B., Seeley, J. R., Duncan, S. C., Lynskey, M. T., Rohde, P., … Lewinsohn, P. M. (2015). Natural course of cannabis use disorders. Psychological Medicine, 45(01), 63–72. doi:10.1017/s003329171400107x
  • Gonzalez, R., Carey, C., & Grant, I. (2002). Nonacute (residual) neuropsychological effects of cannabis use: A qualitative analysis and systematic review. The Journal of Clinical Pharmacology, 42(S1), 48S–57S. doi:10.1002/j.1552-4604(.2002.tb06003.x
  • Goodwin, C. J. (2010). Research in psychology: Methods and design (6th . ed.). Hoboken, NJ: John Wiley & Sons, Inc.
  • Grant, J. E., Chamberlain, S. R., Schreiber, L., & Odlaug, B. L. (2012). Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence, 121(1–2), 159–162. doi:10.1016/j.drugalcdep.2011.08.015
  • Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., … Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder. JAMA Psychiatry, 72(8), 757–766. doi:10.1001/jamapsychiatry.2015.0584
  • Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9(5), 679–689. doi:10.1017/S1355617703950016
  • Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M., & Lukas, S. E. (2012). Age of onset of marijuana use and executive function. Psychology of Addictive Behaviors, 26(3), 496–506. doi:10.1037/a0026269
  • Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., … Grant, B. F. (2015). Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72(12), 1235–1242. doi:10.1001/jamapsychiatry.2015.1858
  • Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiatry, 74(6), 579–588. doi:10.1001/jamapsychiatry.2017.0724
  • Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Miech, R. A. (2015). Monitoring the future national survey results on drug use, 1975–2014: Volume II, college students and adults ages 19–55. Ann Arbor, MI: Institute for Social Research, The University of Michigan. Retrieved from http://www.monitoringthefuture.org/pubs/monographs/mtf-vol2_2014.pdf
  • Kelly, A. B., Chan, G. C. K., Mason, W. A., & Williams, J. W. (2015). The relationship between psychological distress and adolescent polydrug use. Psychology of Addictive Behaviors, 29(3), 787–793. doi:10.1037/adb0000068
  • Keyes, K. M., Martins, S. S., Blanco, C., & Hasin, D. S. (2010). Telescoping and gender differences in alcohol dependence: New evidence from two national surveys. American Journal of Psychiatry, 167(8), 969–976. doi:10.1176/appi.ajp.2009.09081161
  • Khan, S. S., Secades-Villa, R., Okuda, M., Wang, S., Pérez-Fuentes, G., Kerridge, B. T., & Blanco, C. (2013). Gender differences in cannabis use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug and Alcohol Dependence, 130(1–3), 101–108. doi:10.1016/j.drugalcdep.2012.10.015
  • Koppel, B. S., Brust, J. C. M., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), 1556–1563. doi:10.1212/wnl.0000000000000363
  • Lookatch, S. J., Elledge, L. C., Anderson, S., Shorey, R. C., Stuart, G. L., & Moore, T. M. (2017). Cognitive and psychological changes during 28-day residential substance use treatment. Addiction Research & Theory, 25(4), 334–341. doi:10.1080/16066359.2017.1281408
  • Lorenzetti, V., Solowij, N., & Yücel, M. (2016). The role of cannabinoids in neuroanatomic alterations in cannabis users. Biological Psychiatry, 79(7), e17–e31. doi:10.1016/j.biopsych.2015.11.013
  • Lynskey, M. T., Hindocha, C., & Freeman, T. P. (2016). Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use. Addiction, 111(12), 2091–2092. doi:10.1111/add.13390
  • Morisano, D., Babor, T. F., & Robaina, K. A. (2014). Co-occurrence of substance use disorders with other psychiatric disorders: Implications for treatment services. Nordic Studies on Alcohol and Drugs, 31(1), 5–25. doi:10.2478/nsad-2014-0002
  • National Institute of Mental Health. (2016). Mental health medications. Retrieved from www.nimh.nih.gov/health/topics/mental-health-medications/index.shtml
  • Patton, G. C., Coffey, C., Carlin, J. B., Sawyer, S. M., & Lynskey, M. (2005). Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction, 100(10), 1518–1525. doi:10.1111/j.1360-0443.2005.01220.x
  • Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58(10), 909–915. doi:10.1001/archpsyc.58.10.909
  • Rubino, T., & Parolaro, D. (2008). Long lasting consequences of cannabis exposure in adolescence. Molecular and Cellular Endocrinology, 286(1–2), (Suppl. 1), S108–S113. doi:10.1016/j.mce.2008.02.003
  • Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018). Routes of administration for cannabis use–basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy, 52, 87–96. doi:10.1016/j.drugpo.2017.11.008
  • Schulenberg, J. E., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Miech, R. A., & Patrick, M. E. (2017). Monitoring the Future: National survey results on drug use, 1975–2016: Volume II, college students and adults ages 19–55. Ann Arbor, MI: Institute for Social Research, The University of Michigan. Retrieved from http://www.monitoringthefuture.org//pubs/monographs/mtf-vol2_2016.pdf
  • Secades-Villa, R., Garcia-Rodríguez, O., Jin, C. J., Wang, S., & Blanco, C. (2015). Probability and predictors of the cannabis gateway effect: A national study. International Journal of Drug Policy, 26(2), 135–142. doi:10.1016/j.drugpo.2014.07.011
  • Shaffer, J. P. (1995). Multiple hypothesis testing. Annual Review of Psychology, 46, 561–584. doi:10.1146/annurev.ps.46.020195.003021
  • Smith, G. W., Farrell, M., Bunting, B. P., Houston, J. E., & Shevlin, M. (2011). Patterns of polydrug use in Great Britain: Findings from a national household population survey. Drug and Alcohol Dependence, 113(2–3), 222–228. doi:10.1016/j.drugalcdep.2010.08.010
  • Sodos, L. M., Hirst, R. B., Watson, J., & Vaughn, D. (2018). Don't judge a book by its cover: Examiner expectancy effects predict neuropsychological performance for individuals judged as chronic cannabis users. Archives of Clinical Psychology, 1–11. doi:10.1093/arclin/acx114
  • Stinson, F. S., Grant, B. F., Dawson, D. A., Ruan, W. J., Boji, H., & Saha, T. (2006). Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States. Alcohol Research & Health, 29(2), 94–106. Retrieved from https://pubs.niaaa.nih.gov/publications/arh29-2/94-106.htm
  • Tarter, R. E., Vanyukov, M., Kirisci, L., Reynolds, M., & Clark, D. B. (2006). Predictors of marijuana use in adolescents before and after licit drug use: Examination of the gateway hypothesis. The American Journal of Psychiatry, 163(12), 2134–2140. doi:10.1176/ajp.2006.163.12.2134
  • The National Center on Addiction and Substance Abuse. (2017a). Commonly used alcohol and nicotine products. Retrieved from www.centeronaddiction.org/addiction/commonly-used-alcohol-nicotine-products
  • The National Center on Addiction and Substance Abuse. (2017b). Commonly used illegal drugs. Retrieved from www.centeronaddiction.org/addiction/commonly-used-illegal-drugs
  • Taylor, S., & Asmundson, G. (2008). Internal and external validity in clinical research. In D. McKay (Ed.), Handbook of research method in abnormal and clinical psychology (pp. 23–34). Los Angeles, CA: Sage Publications.
  • Thames, A. D., Arbid, N., & Sayegh, P. (2014). Cannabis use and neurocognitive functioning in a non-clinical sample of users. Addictive Behaviors, 39(5), 994–999. doi:10.1016/j.addbeh.2014.01.019
  • United Nations Office on Drugs and Crime (UNODC). (2016). World drug report 2016. ( United Nations publication, Sales No. E.16.XI.7). New York, NY: United Nations Publications. Retrieved from https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf
  • Van Gundy, K., & Rebellon, C. J. (2010). A life-course perspective on the “gateway hypothesis”. Journal of Health and Social Behavior, 51(3), 244–259. doi:10.1177/0022146510378238
  • Verdejo-Garcia, A., Benbrook, A., Funderburk, F., David, P., Cadet, J.-L., & Bolla, K. I. (2007). The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug and Alcohol Dependence, 90(1), 2–11. doi:10.1016/j.drugalcdep.2007.02.004
  • Verdejo-García, A. J., López-Torrecillas, F., Aguilar de Arcos, F., & Pérez-García, M. (2005). Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis. Addictive Behaviors, 30(1), 89–101. doi:10.1016/j.addbeh.2004.04.015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.